"FDA has now issued marketing authorization for those at higher risk: Moderna (6 months and older), Pfizer (5 years and older) and Novavax (12 years and older)," U.S. Health and Human Services ...

MANILA, Aug. 27 (Xinhua) -- The Philippines' Food and Drug Administration (FDA) has approved the country's first vaccine against avian influenza for commercial use, the country's Department of ...